State of New Jersey Common Pension Fund D’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
12,487
-501
-4% -$8.29K ﹤0.01% 1695
2026
Q1
$211K Buy
+12,988
New +$230K ﹤0.01% 1523
2019
Q3
Sell
-265,459
Closed -$4.33M 1639
2019
Q2
$4.33M Hold
265,459
0.02% 603
2019
Q1
$6.02M Hold
265,459
0.02% 542
2018
Q4
$6.79M Hold
265,459
0.03% 470
2018
Q3
$8.67M Hold
265,459
0.03% 459
2018
Q2
$6.02M Buy
265,459
+40,000
+18% +$950K 0.02% 547
2018
Q1
$5.47M Hold
225,459
0.02% 571
2017
Q4
$6.29M Buy
225,459
+65,000
+41% +$1.92M 0.02% 527
2017
Q3
$5.49M Hold
160,459
0.02% 555
2017
Q2
$6.39M Hold
160,459
0.03% 506
2017
Q1
$5.91M Hold
160,459
0.02% 511
2016
Q4
$5.12M Hold
160,459
0.02% 536
2016
Q3
$5.82M Hold
160,459
0.03% 521
2016
Q2
$3.64M Hold
160,459
0.02% 604
2016
Q1
$3.02M Hold
160,459
0.01% 643
2015
Q4
$2.63M Hold
160,459
0.01% 696
2015
Q3
$1.76M Buy
160,459
+35,000
+28% +$446K 0.01% 759
2015
Q2
$1.63M Hold
125,459
0.01% 783
2015
Q1
$2.18M Hold
125,459
0.01% 745
2014
Q4
$1.87M Hold
125,459
0.01% 777
2014
Q3
$2.89M Hold
125,459
0.01% 674
2014
Q2
$4M Buy
+125,459
New +$3.78M 0.02% 609

Other funds holding TBPH

State of New Jersey Common Pension Fund D's TBPH Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Theravance Biopharma (TBPH) stake by 3.9% in Q2 2026, selling an estimated $8.29K and leaving 12,487 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1695.

State of New Jersey Common Pension Fund D first reported a position in TBPH in Q2 2014 and has held it in 23 quarters since. The position peaked at $8.67M in Q3 2018. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 12,487 shares of Theravance Biopharma worth $212K as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 501 Theravance Biopharma shares in Q2 2026, an estimated $8.29K.
  • Theravance Biopharma made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1695 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Theravance Biopharma in Q2 2014 and has held it in 23 quarters since.
  • State of New Jersey Common Pension Fund D's Theravance Biopharma position peaked at $8.67M in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.